Literature DB >> 12724523

Spontaneous regression of advanced cancer: identification of a unique genetically determined, age-dependent trait in mice.

Zheng Cui1, Mark C Willingham, Amy M Hicks, Martha A Alexander-Miller, Timothy D Howard, Gregory A Hawkins, Mark S Miller, Holly M Weir, Wei Du, Cynthia J DeLong.   

Abstract

We have established and studied a colony of mice with a unique trait of host resistance to both ascites and solid cancers induced by transplantable cells. One dramatic manifestation of this trait is age-dependent spontaneous regression of advanced cancers. This powerful resistance segregates as a single-locus dominant trait, is independent of tumor burden, and is effective against cell lines from multiple types of cancer. During spontaneous regression or immediately after exposure, cancer cells provoke a massive infiltration of host leukocytes, which form aggregates and rosettes with tumor cells. The cytolytic destruction of cancer cells by innate leukocytes is rapid and specific without apparent damage to normal cells. The mice are healthy and cancer-free and have a normal life span. These observations suggest a previously unrecognized mechanism of immune surveillance, which may have potential for therapy or prevention of cancer.

Entities:  

Mesh:

Year:  2003        PMID: 12724523      PMCID: PMC164507          DOI: 10.1073/pnas.1031601100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

Review 1.  The spontaneous regression of cancer. A review of cases from 1900 to 1987.

Authors:  G B Challis; H J Stam
Journal:  Acta Oncol       Date:  1990       Impact factor: 4.089

Review 2.  Spontaneous regression of cancer: possible mechanisms.

Authors:  R J Papac
Journal:  In Vivo       Date:  1998 Nov-Dec       Impact factor: 2.155

Review 3.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

Review 4.  Spontaneous regression of cancer.

Authors:  T C Everson
Journal:  Prog Clin Cancer       Date:  1967

5.  Cytokinetics of the S-180 ascites tumor system.

Authors:  L M Schiffer; J S Nelson; B Dilettuso; D Migliorato; W Randolph
Journal:  Cell Tissue Kinet       Date:  1973-03

6.  Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells.

Authors:  L Gorelik; R A Flavell
Journal:  Nat Med       Date:  2001-10       Impact factor: 53.440

7.  Sequential synthesis of two 7 S lysins by rats challenged with mouse sarcoma-180 tumor cells.

Authors:  J W Coffey; H J Hansen
Journal:  J Immunol       Date:  1966-06       Impact factor: 5.422

8.  Immunologic and genetic characterization of S180, a cell line of murine origin capable of growing in different inbred strains of mice.

Authors:  G Alfaro; C Lomeli; R Ocadiz; V Ortega; R Barrera; M Ramirez; G Nava
Journal:  Vet Immunol Immunopathol       Date:  1992-01-31       Impact factor: 2.046

Review 9.  Efforts to explain spontaneous regression of cancer.

Authors:  W H Cole
Journal:  J Surg Oncol       Date:  1981       Impact factor: 3.454

10.  [Interactions between a malignant tumor and a teratoma grafted experimentally in the mouse and in the rat. II. The growth in the same host of a malignant tumor and a benign tumor].

Authors:  J Salaün
Journal:  Eur J Cancer       Date:  1968-08       Impact factor: 9.162

View more
  28 in total

Review 1.  Selection of extreme phenotypes: the role of clinical observation in translational research.

Authors:  José Luis Pérez-Gracia; Alfonso Gúrpide; María Gloria Ruiz-Ilundain; Carlos Alfaro Alegría; Ramon Colomer; Jesús García-Foncillas; Ignacio Melero Bermejo
Journal:  Clin Transl Oncol       Date:  2010-03       Impact factor: 3.405

2.  Strain-specific susceptibility for pulmonary metastasis of sarcoma 180 cells in inbred mice.

Authors:  Haris G Vikis; Erin N Jackson; Alexander S Krupnick; Andrew Franklin; Andrew E Gelman; Qiong Chen; David Piwnica-Worms; Ming You
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

3.  Impact of sex, MHC, and age of recipients on the therapeutic effect of transferred leukocytes from cancer-resistant SR/CR mice.

Authors:  John R Stehle; Michael J Blanks; Gregory Riedlinger; Jung W Kim-Shapiro; Anne M Sanders; Jonathan M Adams; Mark C Willingham; Zheng Cui
Journal:  BMC Cancer       Date:  2009-09-15       Impact factor: 4.430

4.  Transferable anticancer innate immunity in spontaneous regression/complete resistance mice.

Authors:  Amy M Hicks; Gregory Riedlinger; Mark C Willingham; Martha A Alexander-Miller; C Von Kap-Herr; Mark J Pettenati; Anne M Sanders; Holly M Weir; Wei Du; Joseph Kim; Andrew J G Simpson; Lloyd J Old; Zheng Cui
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

Review 5.  The role of natural killer cells in tumor control--effectors and regulators of adaptive immunity.

Authors:  Morgan E Wallace; Mark J Smyth
Journal:  Springer Semin Immunopathol       Date:  2005-02-24

6.  A case of non-functioning huge adrenocortical carcinoma extending into inferior vena cava and right atrium.

Authors:  Kye Hun Kim; Jong Chun Park; Sang Yup Lim; Il Suk Sohn; Kyung Ho Yun; Sang Hee Cho; Young Joon Hong; Hyung Wook Park; Ju Han Kim; Weon Kim; Young Keun Ahn; Ik Joo Chung; Myung Ho Jeong; Jeong Gwan Cho; Jung Chaee Kang
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

7.  Cancer resistance of SR/CR mice in the genetic knockout backgrounds of leukocyte effector mechanisms: determinations for functional requirements.

Authors:  Anne M Sanders; John R Stehle; Michael J Blanks; Gregory Riedlinger; Jung W Kim-Shapiro; Arta M Monjazeb; Jonathan M Adams; Mark C Willingham; Zheng Cui
Journal:  BMC Cancer       Date:  2010-03-31       Impact factor: 4.430

8.  The spectrum of resistance in SR/CR mice: the critical role of chemoattraction in the cancer/leukocyte interaction.

Authors:  Gregory Riedlinger; Jonathan Adams; John R Stehle; Michael J Blanks; Anne M Sanders; Amy M Hicks; Mark C Willingham; Zheng Cui
Journal:  BMC Cancer       Date:  2010-05-03       Impact factor: 4.430

9.  The innate immune system recognizes and regulates major histocompatibility complex class I (MHCI) expression on MHCIlow tumor cells.

Authors:  Bent Rubin; Joëlle Riond; Laetitia Courtiade; Nicolas Roullet; Jean-Edouard Gairin
Journal:  Cancer Immun       Date:  2008-09-11

10.  Tumour cell lines HT-29 and FaDu produce proinflammatory cytokines and activate neutrophils in vitro: possible applications for neutrophil-based antitumour treatment.

Authors:  Antonio Brú; Juan-Carlos Souto; Sonia Alcolea; Rosa Antón; Angel Remacha; Mercedes Camacho; Marta Soler; Isabel Brú; Amelia Porres; Luis Vila
Journal:  Mediators Inflamm       Date:  2010-02-11       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.